Woodside Petroleum Ltd delivered a 27 percent rise in half-year net profit on Wednesday, in line with market forecasts.» Read More
U.S. crude oil futures closed more than $3 lower on Tuesday, extending a slide as a stronger dollar, technical weakness and demand concerns kept the pressure on the oil complex.
Oil rose above $133 on Monday as long-term supply concerns lingered and fresh production problems appeared in Nigeria and Norway.
U.S. crude oil futures rose on Friday after seesawing before dealers bought defensively ahead of a long weekend and as the market eyed a weaker dollar and strikes affecting French port traffic.
This much is clear: European nation states are focusing on different ways of securing energy supplies for the long-term through a mix of politics and innovation.
Oil prices are expected to average above $107 this year and to stay above $102 for the next two years due to concerns over long term supply constraints and strong demand from emerging markets, a Reuters survey of analysts found.
Muscular retail sales figures encouraged traders -- as the dollar slips again and crude oil continues to soar. How should investors read these ostensibly contradictory signs? Erik Ristuben of Russell Investment Group and Holly Isdale of Lehman Brothers offered their sector insights to CNBC.
Crude oil futures leaped to a new all-time high above $120 a barrel, as supply concerns grew and the U.S. dollar weakened against the euro. Retail gasoline and diesel prices eased over the weekend, although pricier oil threatens to push them higher again.
What's wrong with this picture? Crude oil is on a tear, but ExxonMobil shares have barely budged in NINE months. Can tomorrow's earnings knock the oil giant out of its trading range?
Stocks closed mixed in thin trading Tuesday as the tide turned in technology's favor. Airline stocks rose as oil prices receded. Merck skidded after an FDA rejection.
Stocks pushed higher Tuesday despite concerns about interest rates ahead of the Federal Reserve's decision. Merck skidded after an FDA rejection. Airline stocks rose as oil prices receded.
Stocks declined Tuesday amid concerns about interest rates and a slide in consumer confidence. Merck dragged on the Dow industrials after the FDA rejected a key cholesterol drug.
Oil hit a fresh peak near $120 a barrel on Monday as supply outages in Nigeria and Britain shut down nearly 2 million barrels per day (bpd) of output in the Atlantic Basin.
Stocks were indicated to open slightly lower Tuesday, but big moves are unlikely until the Federal Reserve announces its decision on interest rates on Wednesday.
Royal Dutch Shell beat all forecasts on Tuesday with a 12 percent rise in first-quarter current cost of supply (CCS) net income, helped by record oil prices which broke $100 a barrel in the period.
Tuesday could be another wait-and-see day in the markets as investors count down to the Fed's Wednesday afternoon interest rate announcement. But it may be earnings news that has the biggest sway over stocks.
Stocks finished flat Monday as concerns about the Federal Reserve's rate decision in a couple of days kept a lid on activity generated by merger buzz.
Stocks ticked higher Monday amid merger buzz but index gains were modest as the market awaits the Federal Reserve's rate decision later this week.
Stocks retreated after an early pop Monday as the early market buzz was all about deals and deal makers.
Exxon Mobil, Royal Dutch Shell and BP are expected to report bumper first-quarter profits next week, thanks to record crude prices, but $110 per barrel oil will also squeeze refining profits and delay a return to oil production growth.
Singapore state investor Temasek Holdings has set up an oil exploration subsidiary to help diversify its financials-heavy portfolio, entering a sector crowded with expanding national oil companies and majors.